Alzheimer's disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, devastates patients, their families and loved ones. With new treatments ...

Desert June is Alzheimer’s and Brain Awareness Month. More than 7 million Americans ages 65 and older are living with Alzheimer’s disease right now, according to the Alzheimer’s Association.

The Alzheimer’s Association reports that 50-70% of symptomatic patients in community settings are inaccurately diagnosed with Alzheimer’s disease. In specialized memory clinics, this ...

A new study has found the herpes simplex virus type 1 (HSV-1), which causes cold sores, may be linked to the development of Alzheimer's disease. This idea is not entirely new. Previous research ...

NEED TO KNOW The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease The test measures two proteins, beta-amyloid and p-tau217, which are hallmarks of the disease ...

A blood test that can help diagnose Alzheimer’s disease has received clearance from the Food and Drug Administration. This is a step toward a goal of scientists and doctors to one day be able to ...

More than 7 million Americans have Alzheimer’s Disease, according to the Alzheimer’s Association. And one in nine people over the age of 65 has this type of dementia. The disease is believed ...

More than 7 million Americans have Alzheimer’s Disease, according to the Alzheimer’s Association. And one in nine people over the age of 65 has this type of dementia. The disease is believed ...

With the number of Americans living with the disease steadily increasing, scientists predict that 13.8 million will have Alzheimer’s by 2050, or 16% of the US population over the age of 65.

The U.S. Food and Drug Administration (FDA) has granted approval for a first-of-its-kind blood test to help diagnose Alzheimer’s disease, which could help people begin treatment in the early ...

The FDA's sign-off on marketing for Fujirebio's test comes years after other blood tests for Alzheimer's have already begun sales, without this kind of approval from the agency.

WASHINGTON DC - JUNE 20, 2023 Jay Reinstein, right, who suffers from Alzheimer’s, places his hand on his father Max Reinstein’s back prior to to receiving a PET scan at MedStar Georgetown ...